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By remodeling the phagosomal membrane, the type III secretion system encoded within the 
 
Salmonella
 
 pathogenicity island-2 (SPI2) helps 
 
Salmonella
 
 thrive within professional 
phagocytes. We report here that nitric oxide (NO) generated by IFN
 
 
 
-activated macrophages 
abrogates the intracellular survival advantage associated with a functional SPI2 type III 
secretion system. NO congeners inhibit overall expression of SPI2 effectors encoded both 
inside and outside the SPI2 gene cluster, reflecting a reduced transcript level of the sensor 
kinase SsrA that governs overall SPI2 transcription. Down-regulation of SPI2 expression in 
IFN
 
 
 
-treated macrophages does not seem to be the result of global NO cytotoxicity, because 
transcription of the housekeeping 
 
rpoD
 
 sigma factor remains unchanged, whereas the 
expression of the 
 
hmpA
 
-encoded, NO-metabolizing flavohemoprotein is stimulated. Because 
of the reduced SPI2 expression, 
 
Salmonella
 
-containing vacuoles interact more efficiently 
with compartments of the late endosomal/lysosomal system in NO-producing, IFN
 
 
 
-treated 
macrophages. These findings demonstrate that inhibition of intracellular SPI2 transcription 
by NO promotes the interaction of 
 
Salmonella
 
 phagosomes with the degradative compartments 
required for enhanced antimicrobial activity. Transcriptional repression of a type III 
secretion system that blocks phagolysosome biogenesis represents a novel mechanism by 
which NO mediates resistance of IFN
 
 
 
-activated phagocytes to an intracellular pathogen.
 
Intracellular pathogens have developed strategies
to cope with a myriad of oxygen-dependent and
-independent components of the antimicrobial
arsenal of professional phagocytes. For instance,
nonfusogenic intracellular pathogens such as
 
Mycobacterium
 
 and 
 
Salmonella
 
 arrest the biogenesis
of phagolysosomes (1–6). 
 
S enterica
 
 encompasses a
group of related gram-negative bacteria capable
of causing a variety of clinical syndromes that
range from asymptomatic colonization or self-
limiting diarrhea to severe fibrinopurulent necro-
tizing  enteritis and life-threatening systemic
disease. The potential of this enteric pathogen
to cause disseminated disease is intimately asso-
ciated with its ability to replicate within mac-
rophages (7). The type III secretion system
encoded in the SPI2 chromosomal gene cluster
recently has been found to be critical to the
survival of 
 
Salmonella
 
 within professional phago-
cytes (8–11). By altering the trafficking of lyso-
somes, SPI2 effector proteins allow 
 
Salmonella
 
to reside within modified phagosomes that avoid
the terminal stages of the degradative pathway
(12, 13). A functional SPI2 secretion system also
minimizes contact of 
 
Salmonella
 
 phagosomes
with vesicles harboring nicotinamide-adenine
dinucleotide phosphate (NADPH) oxidase or
inducible nitric oxide synthase (iNOS) enzy-
matic complexes (11, 14–16). Therefore, the
SPI2 type III secretion system lessens exposure
of 
 
Salmonella
 
 to a large fraction of the antimicro-
bial arsenal of professional phagocytes, including
an array of lysosomal hydrolytic enzymes and a
battery of reactive oxygen and nitrogen species.
The iNOS enzymatic complex catalyzes the
oxidation of the guanidino group of 
 
L
 
-arginine
for the generation of 
 
L
 
-citrulline and the di-
atomic radical NO (17–19). NO and its con-
geners react with a variety of metal prosthetic
groups, organic and inorganic radicals, lipids,
and DNA molecules (20). It is likely that this
rich biochemistry mediates the broad-spectrum
 
The online version of this article contains supplemental material.
 
CORRESPONDENCE
Andrés Vázquez-Torres: 
andres.vazquez-torres@ 
uchsc.edu
 
Abbreviations used: FRT, Flp 
recombinant target; iNOS, 
inducible nitric oxide synthase; 
MOI, multiplicity of infection; 
NADPH, nicotinamide-adenine 
dinucleotide phosphate; NMMA, 
N
 
G
 
-monomethyl 
 
L
 
-arginine; 
NO, nitric oxide; RNS, reactive 
nitrogen species; SPI2, 
 
Salmonella
 
 
pathogenicity island 2. 
REPRESSION OF SPI2 TRANSCRIPTION | McCollister et al.
 
626
 
antimicrobial activity of reactive nitrogen species (RNS)
against many viruses, bacteria, and fungi, as well as against
protozoan and metazoan parasites. However, specific molec-
ular mechanisms underlying NO-mediated host defense are
not well understood. The gram-negative enteropathogenic
bacteria 
 
Salmonella
 
 also is susceptible to the antimicrobial ac-
tivity of RNS. Multiple independent lines of investigation
assessing the cytotoxicity of chemically generated RNS or
monitoring the effects of pharmacological or genetic inhibi-
tion of iNOS have demonstrated the importance of NO in
host resistance to this enteropathogenic bacterium (21–26).
It is becoming apparent that RNS generated by macrophages
are bacteriostatic for 
 
Salmonella
 
 (27). This NO-mediated an-
timicrobial activity is opposed by 
 
Salmonella
 
’s adaptive anti-
nitrosative response that repairs NO-mediated lesions and
detoxifies a variety of NO congeners (20, 22, 28–31). Re-
cent studies have shown that the 
 
Salmonella
 
 SPI2 type III se-
cretion system adds to the anti-nitrosative defenses of 
 
Salmo-
nella
 
 by avoiding contact with iNOS-containing vesicles
(16). Herein, we report the effects of IFN
 
 
 
-stimulated NO
synthesis on SPI2 function.
IFN
 
 
 
 is essential for the development of protective im-
munity against numerous infectious diseases. An unequivocal
role for IFN
 
 
 
 in host defense against 
 
Mycobacterium
 
 and 
 
Sal-
monella
 
 has been demonstrated definitively by the increased
incidence of these intracellular pathogens in individuals car-
rying defects in the IFN
 
 
 
 signaling pathway (32–35). IFN
 
 
 
probably exerts diverse functions in resistance to these intra-
cellular bacteria. Activation of macrophages by IFN
 
 
 
 is criti-
cal for host defense against 
 
Salmonella
 
 infection (1, 35). Stud-
ies from our laboratory have indicated that IFN
 
 
 
 synergizes
with lipopolysaccharide on the surface of 
 
Salmonella
 
 to en-
hance the transcription of iNOS (36). The resultant high
NO synthesis is associated with profound and long-lasting
anti-
 
Salmonella
 
 activity by IFN
 
 
 
-activated macrophages (27,
37). However, the mechanisms by which IFN
 
 
 
-activated
NO synthesis mediates the anti-
 
Salmonella
 
 activity of mac-
rophages remain largely unknown. We show herein that the
high NO output generated by IFN
 
 
 
-treated macrophages
inhibits SPI2 transcription. Inhibition of SPI2 function facil-
itates the maturation of the 
 
Salmonella
 
 phagosome along the
degradative pathway, contributing to the enhanced anti-
 
Sal-
monella
 
 activity exhibited by NO-producing, IFN
 
 
 
-treated
phagocytic cells. The NO-mediated inhibition of a type III
secretion system represents a novel mechanism by which
IFN
 
 
 
 overcomes the arrest in phagosomal maturation im-
posed by a nonfusogenic intracellular pathogen.
 
RESULTS
NO abrogates the SPI2-dependent intracellular survival 
of 
 
Salmonella
 
The SPI2 type III secretion system prevents maturation of the
 
Salmonella
 
 phagosome along the degradative pathway. Recent
studies have demonstrated that, in addition to thwarting traf-
ficking of lysosomes and vesicles harboring the NADPH oxi-
dase (11, 12, 15), SPI2 decreases contact of 
 
Salmonella
 
 with
iNOS-containing vacuoles (16). To study further the relation
of SPI2 with iNOS, intracellular survival of 
 
Salmonella
 
 was
studied in IFN
 
 
 
-treated macrophages capable of sustaining
high NO output. As anticipated (8–11), after 18 h of contact
with primary macrophages, WT 
 
Salmonella
 
 harboring a func-
tional SPI2 were recovered in higher numbers than its
isogenic 
 
 
 
spiC
 
 mutant strain AV0201 (Fig. 1 A, left). A WT
 
spiC
 
 allele expressed from the low-copy plasmid pWKS29
successfully complemented the growth defect associated with
the 
 
 
 
spiC
 
 mutation. Treatment of macrophages with IFN
 
 
 
resulted in a hundred-fold reduction in the number of 
 
Salmo-
nella
 
 isolated after 18 h of culture and remarkably abrogated
the intracellular growth advantage associated with a func-
tional SPI2. IFN
 
 
 
 treatment also eliminated the SPI2-depen-
dent survival advantage of WT 
 
Salmonella
 
 strain 12023 (Fig. 1
A, right). Macrophages from iNOS-deficient mice were used
to assess whether NO is involved in abrogating the survival
advantage associated with a functional SPI2 secretory system.
In contrast with WT macrophages, enhanced SPI2-mediated
 
Salmonella
 
 survival was seen in IFN
 
 
 
-treated, iNOS-deficient
Figure 1. Abrogation of SPI2-mediated Salmonella survival by 
NO-producing, IFN -treated macrophages. The antimicrobial activity 
of untreated and IFN -treated periodate-elicited macrophages isolated 
from C57BL/6 (A) and iNOS /  mice (B) and J774 macrophage-like cells 
(C) was recorded 18 h after challenge with WT Salmonella Typhimurium 
strain 14028s or 12023 or their isogenic  spiC or sseB::aphT mutant 
strains. The  spiC mutation was complemented with a WT copy expressed 
from the pWKS29 low copy plasmid (A). Selected groups of IFN -treated 
J774 cells were incubated with 250  M of the NOS inhibitor NMMA at the 
time of Salmonella infection. These data are expressed as mean percent 
survival   SEM of 4–18 independent observations from two to six separate 
experiments. *, P   0.05 compared with WT controls. 
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macrophages, suggesting that NO is critical for abrogating the
survival advantage associated with SPI2 (Fig. 1 B). IFN
 
 
 
 also
activated anti-
 
Salmonella
 
 defenses that are independent of NO
synthesis, as suggested by the increased toxicity exhibited by
iNOS-deficient macrophages after IFN
 
 
 
 treatment (Fig. 1
B). Similar to the profiles of intracellular 
 
Salmonella
 
 growth
seen in primary macrophages, the enhanced survival of SPI2-
expressing 
 
Salmonella
 
 was lost upon the activation of J774
cells with IFN
 
 
 
 (Fig. 1 C). This phenotype depended upon
NO synthesis, because the SPI2-dependent growth advantage
was restored by adding the NOS inhibitor N
 
G
 
-monomethyl-
 
L
 
-arginine (NMMA; Fig. 1 C). Together, these data are con-
sistent with the hypothesis that NO produced by IFN
 
 
 
-treated
macrophages inhibits the intracellular survival advantage asso-
ciated with the SPI2 type III secretion system.
 
NO inhibits the expression of 
 
spiC 
 
in vitro
 
To assess whether the NO-mediated inhibition of the intracel-
lular growth associated with SPI2 occurs at the transcriptional
level, 
 
Salmonella
 
 SPI2 gene transcription was assessed in vitro
by measuring the activity of a 
 
spiC::lacZ
 
 transcriptional fusion.
As anticipated (38), culture of 
 
Salmonella
 
 Typhimurium strain
AV0212 in 8 
 
 
 
M MgCl
 
2
 
 N salts medium, pH 6.9, induced
the expression of 
 
spiC::lacZ (Fig. 2 A). To determine whether
NO inhibits spiC expression, the NO donor spermine NON-
Oate was added 1 h after spiC::lacZ-expressing Salmonella had
been subcultured in a low magnesium N salts medium. Sper-
mine NONOate suppressed spiC::lacZ transcription in a con-
centration-dependent manner (Fig. 2 B), and 750  M of sper-
mine NONOate was found to reduce spiC transcription to
levels expressed by controls grown in noninducing high Mg2 
N salts medium. These inhibitory effects of spermine NON-
Oate do not seem to be associated with cytotoxicity, because
Salmonella viability was unaffected by the concentrations of
NO donor used in these experiments (Fig. 2 C).
To rule out inadvertent side effects of the chromosomal
spiC::lacZ transcriptional fusion, spiC transcription was assessed
independently by RT PCR. In accord with the  -galactosi-
dase activity, PCR amplification revealed the induction of spiC
transcription after 3 h of growth in a low magnesium N salts
medium. The expression of spiC was inhibited by 750  M
spermine NONOate (Fig. 2 D, left). In contrast, the expression
of the housekeeping gene rpoD was similar after 30 min and 3 h
of culture and was not affected appreciably by the addition of
spermine NONOate (Fig. 2 D, left). The effects of spermine
NONOate on spiC gene transcription seem to be dependent
on the generation of NO, because comparable amounts of the
parent compound, spermine, did not inhibit spiC expression
(Fig. 2 D, right). A quantitative real-time PCR procedure, in
which the number of spiC transcripts was normalized to inter-
nal rpoD levels, revealed a nearly 1,000-fold inhibition of spiC
expression by spermine NONOate (Fig. 2 E).
Figure 2. NO inhibits Salmonella SPI2 transcription. Expression of 
SPI2 was quantified by measuring  -galactosidase activity of strain AV0212 
expressing a spiC::lacZ transcriptional fusion. The bacteria were grown in 
8  M or 10 mM MgCl2 N salts medium (A) or in 8  M MgCl2 N salts 
medium in the presence of the NO donor spermine NONOate (B). Survival 
of strain AV0212 exposed for 3 h to 750  M spermine NONOate was com-
pared with untreated controls (C). Transcription of spiC and rpoD genes 
was assessed by RT-PCR (D) and real-time RT-PCR amplification (E) of 
RNA samples isolated from WT Salmonella cultured in 8  M MgCl2 N salts 
medium in the presence ( ) or absence ( ) of 750  M spermine NON-
Oate. Spermine was used as a control. Abundance of spiC transcripts is 
expressed relative to internal rpoD levels. The data in A–C and E represent 
the means   SEM of at least three independent experiments. *, P   0.05 
compared with spermine-treated or untreated controls.REPRESSION OF SPI2 TRANSCRIPTION | McCollister et al. 628
Global inhibitory effects of NO on the SPI2 regulon
The SPI2 secretion system translocates substrates encoded
within the SPI2 pathogenicity island and effectors tran-
scribed outside this gene cluster (39–41). To examine
whether NO has global effects on SPI2 expression, addi-
tional lacZ transcriptional fusions were constructed for sseE,
which is an effector protein encoded within SPI2, and for
sifA, srfJ, and sspH2, which are encoded outside the island.
Similar to spiC, the NO donor spermine NONOate inhib-
ited transcription of sifA, sspH2, srfJ, and sseE (Fig. 3 A). The
transcription of sifA and sseG also was inhibited by spermine
NONOate as determined by RT-PCR analysis of RNA ex-
tracts isolated from Salmonella grown for 30 min or for 3 h in
SPI2-inducing low Mg2  N salts medium (Fig. 3 B). To-
gether, these results suggest that NO exerts a global inhibi-
tion of transcription of SPI2 regulated genes.
The two-component SsrAB regulatory system encoded
within the SPI2 gene cluster is a global regulator of SPI2
function. We therefore examined by RT-PCR whether
transcription of the sensor kinase encoded by ssrA was af-
fected by exposure to NO. Growth of Salmonella for 3 h in
SPI2-inducing low Mg2  N salts medium stimulated ssrA
expression (Fig. 3 C). The transcription of ssrA was inhibited
in response to spermine NONOate, suggesting that nitrogen
oxides block SPI2 expression by directly or indirectly acting
upon the master two-component SsrAB regulatory system.
Induction of hmp by NO
The expression of the NO-detoxifying Salmonella flavohe-
moglobin Hmp is positively induced by the transcriptional
regulator Fur in response to nitrosative stress (28). The ex-
pression of hmp was monitored to examine whether NO-
mediated inhibition of SPI2 transcription is caused by non-
specific cytotoxicity of this diatomic radical or its congeners.
RT-PCR showed that the expression of hmp was up-regu-
lated after 3 h of culture in the presence of the NO donor
spermine NONOate (Fig. 3 D). As described earlier, the ex-
pression of the housekeeping gene rpoD was unaffected by
exposure of Salmonella to this NO donor. An hmp::lacZ tran-
scriptional fusion revealed a nearly 10-fold up-regulation of
hmp transcription upon exposure to NO (Fig. 3 E).
The expression of spiC is down-regulated in NO-producing, 
IFN -treated macrophages
We next tested whether NO produced by IFN -treated mac-
rophages decreases intracellular SPI2 transcription. PCR analysis
revealed that spiC expression was inhibited selectively in J774
cells treated with IFN . Addition of 250  M of the NOS in-
Figure 3. NO inhibits transcription of SPI2 effectors encoded in 
multiple loci of the Salmonella chromosome. (A) The effect of NO on 
transcription of several SPI2 lacZ transcriptional fusions was analyzed by 
measuring  -galactosidase as described in Fig. 2. These data represent the 
means   SEM of two to five independent observations from two separate 
experiments. Transcription of the sifA and sseG SPI2 effectors (B) and the 
ssrA sensor kinase (C) was assessed by RT-PCR of RNA samples isolated 
from WT Salmonella grown in SPI2-inducing conditions in the presence or 
absence of the NO generator spermine NONOate as outlined in Fig. 2. 
(D) RT-PCR of hmp and rpoD transcripts isolated from Salmonella cultures 
grown in 8  M MgCl2 N salts medium in the presence or absence of 750  M 
spermine NONOate. (E) The effects of the NO on hmp transcription were 
independently studied by measuring the activity of the hmp::lacZ tran-
scriptional fusion expressed by Salmonella strain AV0305. The bacteria 
were grown in 8  M MgCl2 N salts medium in the presence or absence 
of 750  M spermine NONOate. These data represent the means   SD of 
three independent observations.
Figure 4. Inhibition of SPI2 transcription by NO-producing, IFN -
treated macrophages. Transcription of spiC and rpoD was assessed by 
RT-PCR (A, C) and real-time RT-PCR (B) of samples isolated from J774 (A, B) or 
primary macrophages isolated from C57BL/6 (B6) or iNOS-immunodeficient 
(iNOS) mice (C). Total RNA was isolated from untreated or IFN -treated 
macrophages 18 h after Salmonella challenge. 250  M NMMA (A and B) 
was added to selected J774 macrophages after Salmonella challenge. The 
rates of nitrite synthesis sustained by primary macrophages isolated from 
C57BL/6 or iNOS /  mice were recorded after 12 h of Salmonella infection 
(D). Data in panels B and D represent the mean   SEM of three indepen-
dent experiments.JEM VOL. 202, September 5, 2005 629
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hibitor NMMA restored spiC expression to control levels, sug-
gesting that the RNS produced by IFN -treated macrophages
abrogate SPI2 expression (Fig. 4 A). Real-time RT-PCR
showed an  10-fold decrease in the number of spiC transcripts
in IFN -treated macrophages compared with untreated con-
trols (Fig. 4 B). Addition of the NOS inhibitor NMMA to
IFN -treated, Salmonella-challenged J774 cells inhibited nitrite
synthesis (unpublished data) and restored spiC expression. NO
produced by IFN -treated primary macrophages also inhibited
spiC transcription (Fig. 4 C). In contrast to this SPI2 gene, the
expression of hmp was increased in response to NO produced
by IFN -treated macrophages. As anticipated (27), IFN  ele-
vated the rate of NO synthesized by primary macrophages (Fig.
4 D). Together, these data suggest that the high rates of NO
synthesized in response to IFN  down-regulate SPI2 transcrip-
tion, thus abrogating the survival advantage associated with a
functional SPI2.
Functional iNOS is sufficient for the IFN -dependent 
inhibition of SPI2 transcription
The effects of IFN -stimulated NO synthesis on SPI2 ex-
pression were studied in more detail. IFN -treated mac-
rophages exerted similar rates of killing against WT or spiC-
deficient Salmonella in all the time points examined (Fig. 5
A). The increased numbers of WT Salmonella recovered
from IFN -treated, iNOS-deficient macrophages were al-
ready evident after 6 h of infection. As shown in Fig. 1, the
lack of iNOS had little effect on the intracellular survival of
the spiC mutant strain, suggesting that the inhibition of the
SPI2-dependent survival is a key target of NO-mediated cy-
totoxicity. In support of this hypothesis, intracellular spiC
transcript levels were consistently higher at all time points
examined in control macrophages lacking iNOS (Fig. 5 B).
To study whether the early inhibition of spiC expression by
NO-producing, IFN -activated macrophages involves me-
tabolites generated during the respiratory burst, spiC expres-
sion was examined in gp91phox-deficient macrophages. The
transcriptional analysis shown in Fig. 5 C indicates that the
NO-mediated inhibition of spiC transcription sustained by
IFN -treated macrophages can be achieved in the absence of
a functional NADPH oxidase.
NO promotes the maturation of the Salmonella phagosome 
along the degradative pathway
Salmonella is a nonfusogenic intracellular pathogen (2–4, 42,
43). Through the actions of the SPI2 type III secretion sys-
tem, Salmonella prevents the maturation of its phagosome
and avoids contact with NADPH oxidase- and iNOS-con-
taining vesicles and lysosomes (11, 12, 15, 16). Because SPI2
expression is inhibited by biologically generated NO (Figs. 4
and 5), we hypothesized that the IFN -induced high NO
output endows macrophages with the capacity to process
Salmonella along the degradative pathway. This hypothesis
was tested by monitoring the intracellular localization of
Texas red-dextran–labeled late endosomes/lysosomes and
GFP-expressing Salmonella (Fig. 6). A functional SPI2 system
allowed   20% of contact between late endosomes/lyso-
somes and Salmonella (Fig. 6, A and H). In some instances,
WT Salmonella were separated from late endosomes and ly-
sosomes by the host cell nucleus. In contrast, the absence of
a functional SPI2 allowed  70% of the Salmonella phago-
somes to acquire the late endosome/lysosome marker (Fig.
6, C and E). Treatment of J774 cells with IFN  resulted in
the maturation of phagosomes containing WT Salmonella
along the degradative pathway, resulting in  70% colocal-
ization of Salmonella with late endosomes/lysosomes (Fig. 6,
F and G). This process seems to depend on the actions of
NO congeners, because 30% of Salmonella-containing vacu-
oles in IFN -activated J774 cells that were treated with the
NOS inhibitor NMMA acquired the late endosome/lyso-
some marker (Fig. 6 H).
The effects of IFN  on the maturation of the Salmonella
phagosome were studied independently by transmission
electron microscopy in primary macrophages isolated from
WT C57BL/6 mice or from immunodeficient controls
lacking iNOS or gp91phox. The maturation of Salmonella
phagosomes was visualized by their colocalization with lyso-
somes that had been marked with colloidal gold-labeled
BSA. Consistent with the data presented in Fig. 6, a small
fraction of the phagosomes containing WT Salmonella ma-
tured into phagolysosomes (Fig. 7, A and G). IFN  treat-
ment greatly enhanced the interaction of Salmonella with ly-
sosomes (Fig. 7, B, C, and G). In most cases, Salmonella was
found in various states of digestion in the phagolysosomes of
Figure 5. The NO-dependent inhibition of SPI2 expression in 
IFN -activated macrophages does not require a respiratory burst. 
(A) The survival of WT or  spiC::FRT Salmonella was determined in IFN -
activated macrophages at several time points after infection as described 
in Fig. 1. (B) Temporal spiC transcription was tested in WT Salmonella 
grown in WT (B6) or iNOS /  macrophages treated with 200 U/ml IFN . 
The abundance of spiC transcripts was estimated by real-time RT-PCR as 
described in Fig. 2. (C) spiC and rpoD expression was estimated by RT-PCR 
of samples isolated from WT (B6), iNOS / , or gp91phox /  peritoneal 
macrophages 16 h after challenge with Salmonella strain 14028s. Selected 
groups of macrophages were treated with IFN  ( ).REPRESSION OF SPI2 TRANSCRIPTION | McCollister et al. 630
IFN -treated macrophages. However, in some instances,
intact  Salmonella were found in spacious phagolysosomes
containing multiple electrodense DNA conglomerates (Fig.
7 C). The absence of iNOS resulted in a marked reduction
in the proportion of Salmonella phagosomes that colocalized
with lysosomes (Fig. 7, D and G). Remarkably, in the ab-
sence of a functional NADPH oxidase, IFN -activated
macrophages were unable to deliver lysosomes to the Salmo-
nella phagosome (Fig. 7, D and E), despite their ability to re-
duce SPI2 expression (Fig. 5). In fact, only 3% of the Salmo-
nella vacuoles became phagolysosomes in IFN -treated
macrophages lacking the gp91phox subunit of the NADPH
oxidase (Fig. 7 G). Similarly, IFN -treated gp91phox / 
macrophages were unable to mature phagosomes containing
spiC-mutant Salmonella along the degradative pathway (un-
published data). As anticipated by these remarkable findings,
the SPI2 type III secretion system seems to be dispensable
for the survival of Salmonella in IFN -treated, gp91phox / 
macrophages (Fig. 7 H).
DISCUSSION
The data presented herein demonstrate that NO congeners
synthesized by IFN -activated macrophages exert a pro-
found inhibitory effect on the transcription of the SPI2 type
III secretion system. Inhibition of SPI2 transcription pro-
motes the maturation of the Salmonella phagosome along the
degradative pathway, facilitating a close interaction of the
Salmonella-containing vacuole with late endosomes and lyso-
somes. The NO-mediated inhibition of SPI2 transcription is
manifested functionally by the enhanced anti-Salmonella ac-
tivity of IFN -treated macrophages. Because Salmonella
strains that lack a functional SPI2 secretion system survive
poorly in macrophages and exhibit a profound inability to
cause systemic disease (8–11, 44), inhibition of SPI2 by NO
may represent a mechanism by which IFN  contributes crit-
ically to resistance to naturally acquired or experimentally
induced Salmonella infections.
Transcriptional analysis of Salmonella exposed to NO
generated chemically or synthesized enzymatically by acti-
Figure 6. NO stimulates progression of the Salmonella phagosome 
along the degradative pathway. The intracellular localization of Texas 
red-dextran–labeled late endosomes/lysosomes (red), GFP-expressing 
Salmonella (green), and DAPI-labeled host cell nucleus (blue) was visualized 
by fluorescence microscopy. J774 cells were infected with either WT 
Salmonella (A and B) or its isogenic sseB mutant control (C–E). Selected 
groups of J774 cells were treated with IFN  20 h before infection with WT 
Salmonella (F and H). Samples were prepared for immunofluorescence 
microscopy 20 h after Salmonella infection and after 1 h of pulsing with 
Texas red-dextran. The percentage of Salmonella colocalizing with late 
endosomes/lysosomes is shown in H. These data represent an analysis of 
330 independent observations from five separate experiments.JEM VOL. 202, September 5, 2005 631
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vated macrophages has revealed that nitrogen oxides inhibit
overall transcription of SPI2 genes, including the effectors
sspH2, srfJ, and sifA that are encoded outside the SPI2 gene
cluster. The global inhibition of SPI2 transcription reflects
the negative effects of NO on the expression of ssrA, which
encodes a sensor kinase within the ssrAB operon located in
the SPI2 pathogenicity island (9, 45). The two-component
regulatory system SsrAB controls the expression of SPI2
genes encoding chaperons, subunits of the type III secretion
apparatus and translocon, and a plethora of effectors (38, 40,
41, 45, 46). Expression of SPI2 is induced shortly after Sal-
monella enters into macrophages and is dependent upon the
presence of a functional SsrAB two-component regulatory
system (9, 10). Accordingly, lack of ssrA abrogates intracellu-
lar SPI2 expression and diminishes the resistance of Salmo-
nella to the antimicrobial defenses of macrophages (9).
Therefore, direct or indirect inhibition of ssrA expression by
NO seems to be responsible for the general down-regulation
of SPI2 expression and also may contribute to the enhanced
anti-Salmonella activity of IFN -treated macrophages. Cys-
teines present in the response regulators SsrB and OmpR,
both of which directly control ssrA transcription (47, 48), are
potential targets for NO-mediated SPI2 inhibition.
Our data indicate that the inhibition of SPI2 function by
NO is critical for the anti-Salmonella activity of IFN -treated
macrophages. In addition, the recovery of higher numbers of
SPI2-deficient  Salmonella from activated macrophages that
cannot sustain NO production (Fig. 1) suggests that nitrogen
oxides also inhibit targets unrelated to SPI2 function. Many
proteins, including a variety of dehydratases, organic radicals,
and enzymes involved in DNA synthesis and replication, may
represent such targets (20). However, our data indicate that
these targets are of lesser importance than the effects of NO
on SPI2. This conclusion is supported by NO’s mediating a
threefold reduction in the numbers of SPI2-deficient Salmo-
nella recovered from IFN -treated macrophages, as com-
pared with a 30-fold decrease for SPI2-sufficient controls.
The presence of a functional SPI2 does not restore com-
plete survival of Salmonella in IFN -treated macrophages
lacking iNOS. This observation is consistent with the view
that IFN  also induces anti-Salmonella defenses that are inde-
pendent of NO synthesis. In analogy to the intracellular
pathogen Mycobacterium (6), it is possible that IFN  promotes
degradative maturation of the Salmonella phagosome through
the up-regulation of small guanosine triphosphatases. In sup-
port of this view, the percentage of Salmonella phagosomes
that associate with late endosomes/lysosomes is higher upon
IFN  treatment, even in the absence of NO synthesis (Figs.
6 and 7). In addition to promoting NO-dependent and
-independent phagosomal maturation, IFN  may increase
the anti-Salmonella activity of macrophages through its posi-
tive effects on NADPH oxidase transcription (49).
The SPI2 secretion system has been shown to prevent
trafficking of vesicles containing the iNOS hemoprotein to
the  Salmonella phagosome (16). The avoidance of iNOS-
containing vesicles may represent an important protection
mechanism against the low NO fluxes sustained during the
innate host response. Nevertheless, the SPI2 type III secre-
tion system does not seem to prevent these relatively low
levels of NO from reaching Salmonella completely. A possi-
ble explanation is that, even though NO possesses an un-
paired electron, this diatomic radical diffuses freely through
lipid membranes (50). The lipid solubility of NO may ex-
plain the stimulation of hmp transcription in macrophages
exhibiting low rates of NO synthesis (Fig. 4). Therefore, the
inhibition of SPI2 transcription by NO seems to depend on
Figure 7. NO-dependent progression of Salmonella phagosomes 
along the degradative pathway in IFN -treated macrophages. 
Interaction of Salmonella phagosomes with lysosomes was evaluated 
by transmission electron microscopy 16 h after infection. Lysosomal 
localization was visualized as electrodense colloidal gold (25 nm)–
labeled BSA particles in primary macrophages isolated from C57BL/6 
(A–C), iNOS /  (D), or gp91phox /  (E and F) mice. Selected groups 
of macrophages (B–F) were treated with 200 U/ml IFN  16 h before 
challenge. Data in G represent the analysis of 253 phagosomes. Bars, 
0.5  m (A–E); 2  m (F). (H) The survival of WT or spiC-deficient Salmonella 
was studied in untreated or IFN -treated gp91phox /  macrophages 
16 h after infection.REPRESSION OF SPI2 TRANSCRIPTION | McCollister et al. 632
the rate of synthesis of this diatomic radical. It is likely that,
at the low rates of NO that are generated by unstimulated
macrophages, the NO dioxygenase Hmp (51), together with
other anti-nitrosative defenses such as glutathione, homocys-
teine, and glutathione reductase (20, 52) allows Salmonella
SPI2 transcription. However, at higher rates of NO synthe-
sis, such as those sustained by IFN -activated macrophages
(Fig. 4 D; reference 27), SPI2 transcription is inhibited, de-
spite the presence of increased hmp expression (Fig. 4 C).
The down-regulation of SPI2 transcription seen in IFN -
treated macrophages could be interpreted as a key action of
NO-related antimicrobial activity. Down-regulation of SPI2
in turn may allow Salmonella to expend its energy on an
adaptive response to the nitrosative stress characteristic of the
late phases of salmonellosis (25, 27).
The NO-mediated inhibition of spiC expression can occur
in the absence of a functional NADPH oxidase. These find-
ings suggest that ONOO  generated by the combined actions
of the NADPH oxidase and iNOS hemoproteins is not re-
sponsible for the SPI2 inhibition seen in IFN -activated mac-
rophages. However, these data do not rule out the possibility
that ONOO  produced endogenously by the reaction of NO
generated by the phagocyte and superoxide released by the
bacteria mediates inhibition of SPI2 transcription. Of note, the
inhibition of SPI2 expression in gp91phox-deficient macro-
phages is not followed by an increase anti-Salmonella activity.
These unexpected findings might be explained by our obser-
vation that NADPH oxidase–deficient macrophages are un-
able to fuse lysosomes with Salmonella phagosomes. This novel
role for the NADPH oxidase in the terminal stages of the deg-
radative pathway seems to be different from the effect of the
respiratory burst on the release of neutral proteases from the
negatively charged proteoglycan matrix of acidic granules (53).
In summary, the present study has revealed a new mech-
anism by which IFN  promotes progression of a nonfuso-
genic intracellular pathogen along the degradative pathway.
RNS produced in response to IFN  inhibit the transcription
of the SPI2 type III secretion system that is essential for re-
modeling the Salmonella phagosomal membrane. Inhibition
of SPI2 by NO may predispose Salmonella to a vast array of
effectors from the armamentarium of activated macrophages.
For instance, NO facilitates the interaction of Salmonella
with late endosomes/lysosomes, and thus it contributes to
the enhanced anti-Salmonella activity exhibited by IFN -
treated macrophages.
MATERIAL AND METHODS
Bacterial strains. Salmonella enterica serovar Typhimurium strain ATCC
14028s was used throughout this study as WT and as the background for
the construction of mutations of several SPI2 genes and the hmp-encoded
flavohemoprotein (Table S1, available at http://www.jem.org/cgi/con-
tent/full/jem.20050246/DC1). The mutations were engineered following
the one-step,   red–mediated gene replacement method originally de-
scribed by Datsenko and Wanner (54). Briefly, primers encoding 60 nucle-
otides homologous to the target gene followed by 20 nucleotides homolo-
gous to the pKD13 plasmid were used for the PCR amplification of the Flp
recombinant target (FRT)-flanked kanamycin resistance cassette encoded
within the pKD13 plasmid. The resulting PCR product was DpnI-digested
and electroporated into Salmonella Typhimurium strain TT22236 carrying
the pTP2223 plasmid that expresses the   red recombinase under Ptac con-
trol (55). Mutations were moved into Salmonella Typhimurium strain
14028s by bacteriophage P22–mediated transduction, and pseudolysogens
were eliminated by streaking on Evans blue uranine agar plates. The kana-
mycin-cassette was excised by recombining the flanking FRT sites, which
serve as site-specific substrates for the Flp recombinase encoded within the
pCP20 plasmid (56). The ‘scars’ in the sifA, srfJ, sspH2, sseE, spiC, and sseG
SPI2 genes and hmp containing a single FRT site were confirmed by PCR,
and the resultant mutants were used for the construction of chromosomal
lacZ transcriptional fusions following the method described by Ellenmeier et
al. (57). Accordingly, the pCE36 plasmid, which carries a promoterless lacZ
gene downstream from a unique FRT site, was integrated in the SPI2 or
hmp FRT ‘scars’ after transformation with the temperature-sensitive pCP20
plasmid expressing the Flp recombinase.
Macrophages. C57BL/6 and congenic iNOS /  (58) or gp91phox / 
(59) mice were bred in our animal facility according to Institutional Animal
Care and Use Committee guidelines. Peritoneal macrophages were har-
vested from mice 4 d after intraperitoneal inoculation of 1 mg/ml sodium
periodate as described (22). The peritoneal exudate cells were resuspended
in RPMI 1640 medium (Cellgro; Mediatech, Inc.) supplemented with 10%
heat-inactivated FBS (BioWhittaker Inc), 15 mM Hepes, 2 mM L-gluta-
mine, 1 mM sodium pyruvate (Sigma-Aldrich), and 100 U   ml 1/100 mg  
ml 1 of penicillin/ Lakes streptomycin (Cellgro). The peritoneal exudate
cells were seeded in 24-well plates (Falcon) for spiC transcriptional studies
or 96-well plates for macrophage-killing assays. The macrophages were se-
lected by adherence after 48 h of culture at 37 C in a 5% CO2 incubator.
J774 murine macrophage-like cells (clone ATCC TIB-67) grown in RPMI
1640 medium supplemented as described earlier were used as an additional
source of mononuclear phagocytes. Selected groups of macrophages were
treated with 200 U/ml of IFN  (Life Technologies) during the last 20 h of
culture before Salmonella infection.
Macrophage killing assays. Macrophages were challenged at a multiplic-
ity of infection (MOI) of 2 with WT Salmonella strains 14028s or 12023 and
their spiC or sseB isogenic controls. The bacteria were opsonized with 10%
normal mouse serum for 20 min before infection. To ensure that the pheno-
types associated with the  spiC::FRT mutation are not caused by polar ef-
fects on downstream genes of the SPI2 operon, strain AV0201 was trans-
formed with the low copy number pWKS29 vector expressing a WT spiC
allele under the control of its native promoter. Extracellular bacteria were re-
moved from the monolayers 25 min after challenge by washing with pre-
warmed RPMI 1640 medium containing 6  g/ml of gentamicin (Sigma-
Aldrich) (22). The Salmonella-infected macrophages were lysed at indicated
time points after challenge, and the surviving bacteria were enumerated on
Luria-Bertani agar plates. The results are expressed as percentage survival.
Effects of NO on in vitro SPI-2 expression. SPI2 expression was in-
duced in vitro by culturing Salmonella in low osmolarity N salts medium as de-
scribed (38). Briefly, Salmonella Typhimurium strains harboring lacZ transcrip-
tional fusions were grown overnight in high Mg2  N salts medium [5 mM
KCl, 7.5 mM (NH4)2SO4, 0.5 mM K2SO4, 1 mM KH2PO4, 38 mM glycerol,
0.1% casamino acids supplemented with 10 mM MgCl2 and 100 mM Tris-
HCl], pH 7.6. The bacteria were subcultured in high Mg2  N salts medium
and grown at 37 C in a shaker incubator until they reached an OD600 of 0.5.
SPI2 expression was induced by switching the bacteria to 8  M MgCl2 N salts
medium, pH 6.9. The expression of SPI2 lacZ transcriptional fusions was
quantified spectrophotometrically as  -galactosidase enzymatic activity using
the substrate o-nitrophenyl- -D-galactopyranoside (Sigma-Aldrich; reference
60).  -galactosidase activity is expressed in Miller units according to the equa-
tion: 1,000   [(OD420   1.75   OD550)]/(T(min)   V(ml)   OD600).
The NO donor spermine NONOate (Cayman Chemical) was used to
determine the effects of RNS on SPI2 transcription. Spermine NONOateJEM VOL. 202, September 5, 2005 633
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dissolved in 10 mM Tris-HCl, pH 7.4, was quantified spectrophotometri-
cally using  252   8,500 M 1 cm 1. The NO donor was added to the cul-
tures after Salmonella had been grown for 1 h in 8  M MgCl2 N salts me-
dium, a time at which the bacterial cells had reached late log phase.
Synthesis of SPI2 cDNA from bacterial cultures and Salmonella-
infected macrophages. Total RNA was isolated from bacterial cultures
grown in 8  M MgCl2 N salts medium or from Salmonella-infected mac-
rophages. The samples were resuspended in TRIzol reagent (Invitrogen)
containing silicon beads and processed in a bead-beater (Biospec Products,
Inc.). The RNA, extracted with chloroform, was precipitated in a 1:1 mix-
ture of isopropyl alcohol: 0.8 M sodium citrate solution, washed in ethanol,
and dried in a speed vacuum. The samples were resuspended in RNAase-
free H2O and were digested with RNase-free DNase (Promega). The RNA
was purified further using an RNeasy kit following the protocol recom-
mended by the manufacturer (QIAGEN). Complementary cDNA was syn-
thesized at 42 C for 30 min using MMLV reverse transcriptase (Promega),
RNasin (Promega), dNTPs, and reverse primers for the genes of inter-
est (Table S2, available at http://www.jem.org/cgi/content/full/jem.20050246/
DC1). The cDNA was used as template for standard PCR and real-
time PCR.
Quantification of SPI2 transcripts by PCR and real-time PCR.
PCR reactions were performed using Salmonella cDNA, dNTPs, Taq DNA
polymerase (Continental Lab Products), and forward and reverse primers
(Table S2). PCR products were visualized under UV light after electro-
phoresis. The real-time PCR reactions contained cDNA, Takara OmniMi
HS (Takara Bio Inc.), forward and reverse primers and fluorescent-labeled
DNA probes for the spiC gene or the housekeeping sigma factor rpoD (Ta-
ble S2). Real-time PCR reactions consisted of a cycle at 94 C for 45 s fol-
lowed by 45 cycles at 94 C for 5 s and at 59 C for 30 s The resulting fluo-
rescence was recorded using the SmartCycler II thermocycler (Cepheid).
Analysis of phagosomal maturation by fluorescence microscopy.
J774 cells cultured on Permanox slides (Nalge Nunc International) were in-
fected at a MOI of 2 with GFP-expressing Salmonella strains FF0001 or
FF0002 that are proficient or deficient for the sseB component of the SPI2
translocon, respectively. After 20 h of infection, the cells were pulsed for 15
min with 0.1 mg/ml of 10,000 molecular weight Texas red–labeled dextran
(Molecular Probes), a fluid phase marker that accumulates in late endo-
somes/lysosomes (61, 62). The cells were fixed in paraformaldehyde (Elec-
tron Microscopy Sciences) after 1 h of chasing and were mounted with a
coverslip in Vectashield containing the DNA stain DAPI. The specimens
were analyzed in a fluorescence microscope for the cellular distribution of
Salmonella (green), late endosomes/lysosomes (red), and host cell nucleus
(blue). To study the effects of macrophage activation on the maturation of
the  Salmonella phagosome, selected groups of macrophages were treated
with 200 U/ml of IFN  20 h before Salmonella infection. The role of NO
on the progression of Salmonella-containing vacuoles to phagolysosomes was
studied by adding 250  M of the NOS inhibitor NG-monomethyl-L-argi-
nine (Sigma-Aldrich) at the time of the infection.
Analysis of phagosome/lysosome fusion by electron microscopy.
Progression of the Salmonella phagosome along the degradative pathway was
studied independently by transmission electron microscopy. Lysosomal
compartments of periodate-elicited macrophages isolated from C57BL/6
mice or congenic iNOS- or gp91phox-deficient controls were pulse/chased
with BSA-gold (25-nm) tracer (OD520   0.5; Electron Microscopy Sci-
ences). Extracellular BSA-gold particles were washed with PBS after 4 h of
pulsing, and the macrophages were incubated for an additional 3 h before
infection. The phagocytes were then challenged with WT Salmonella at a
MOI of 2 as described earlier. The infected cells were fixed in 2.5% glutar-
aldehyde in phosphate buffer, pH 7.4, after 16 h of challenge, and the spec-
imens were postfixed in 1% osmium tetraoxide, treated with uranyl acetate,
dehydrated in ascending ethanol series, and infiltrated with Embed 812
(Electron Microscopy Sciences). Ultrathin sections were examined in a FEI
Technai 62 electron microscope operated at 80 kV.
Statistical analysis. Data are expressed as mean   SEM. The data were
analyzed using a paired Student’s t test.
Online supplemental material. Table S1 lists the bacterial strains and
plasmids used in this study. Table S2 shows the nucleotide sequences for the
PCR primers used in mutational and complementation analysis.Online sup-
plemental material is available at http://www.jem.org/cgi/content/full/
jem.20050246/DC1.
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